Physician profile
Philip G Wong
NPI 1003208026
$10,738.65
in general payments reported to CMS, 2019-2025
33 companies · $2,378 in 2025
The $2,378 reported for 2025 was more than what 83% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.15 · 2020: $129 · 2021: $59.14 · 2022: $916 · 2023: $365 · 2024: $6,802 · 2025: $2,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $3,648 · Food and Beverage: $1,820 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $77.48.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $3,648.05 |
| Food and Beverage | $1,819.68 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $77.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,188.96 | 2023-2025 | |
| Procept Biorobotics Corporation | $1,241.20 | 2020-2024 | Aquabeam System, Aquabeam Robotic System |
| Valencia Technologies Corporation | $667.41 | 2022 | |
| Sumitomo Pharma America, INC. | $158.15 | 2023-2025 | Orgovyx, Gemtesa, Myfembree |
| Antares Pharma, INC. | $156.70 | 2022-2025 | Xyosted |
| Convatec INC. | $147.35 | 2023-2024 | |
| Janssen Scientific Affairs, LLC | $133.51 | 2025 | Erleada, Akeega, Balversa |
| Boston Scientific Corporation | $128.34 | 2019-2024 | |
| Abbvie INC. | $123.86 | 2023-2025 | Lupron Depot |
| Medtronic, INC. | $118.67 | 2022 | |
| Janssen Biotech, INC. | $62.96 | 2024-2025 | Erleada |
| Myovant Sciences INC. | $60.14 | 2021-2022 | |
| Tolmar, INC. | $59.98 | 2025 | Jatenzo, Eligard |
| Urogen Pharma, INC. | $53.63 | 2023-2025 | Jelmyto |
| Immunitybio, INC. | $49.37 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $47.08 | 2022-2025 | Barrigel, Urolift |
| Coloplast Corp | $35.52 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $31.45 | 2023-2024 | |
| Ferring Pharmaceuticals INC. | $29.62 | 2025 | Adstiladrin |
| Amgen INC. | $26.58 | 2023-2024 | Prolia |
| Pacira Pharmaceuticals Incorporated | $24.16 | 2025 | Exparel |
| Integra Lifesciences Corporation | $20.95 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $19.98 | 2025 | |
| Merck Sharp & Dohme LLC | $19.57 | 2023 | Keytruda, Lynparza |
| Blue Earth Diagnostics | $19.07 | 2025 | Posluma |
| Myriad Genetic Laboratories, INC. | $18.31 | 2025 | Prolaris |
| C. R. Bard, INC. & Subsidiaries | $17.21 | 2025 | Purewick Female External Catheter |
| Endo USA, INC. | $16.33 | 2025 | Xiaflex |
| Abc Home Medical Supply, INC. | $15.59 | 2023 | |
| Astellas Pharma US INC | $15.18 | 2022 | |
| Urovant Sciences INC | $12.83 | 2022 | |
| Endo Pharmaceuticals INC. | $12.17 | 2022 | |
| Laborie Medical Technologies Corp. | $6.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.